New York, New York (PRWEB) May 01, 2014
A transvaginal mesh lawsuit (http://www.transvaginalmeshlawsuithelp.com/)
settlement announced by Endo International PLC could resolve the majority of claims filed on behalf of women who were allegedly injured by devices marketed by its subsidiary, American Medical Systems, Inc., Bernstein Liebhard LLP reports. According to a statement issued by the company on April 30, 2014, Endo has set aside $830 million to cover the settlement agreement, which is expected to be implemented over the next year. Individual settlements are subject to a number of requirements, including verification that a claimant received transvaginal mesh manufactured by American Medical Systems. In reaching the agreement to settle the vaginal mesh lawsuits, Endo did not admit any liability or fault.*
“Our Firm is representing numerous women who have filed transvaginal mesh lawsuits against American Medical Systems. We are very encouraged by this development,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate vaginal mesh lawsuits on behalf of women who suffered mesh erosion, chronic pain, and organ damage, allegedly due to devices marketed by American Medical Systems, as well as Boston Scientific Corp., C.R. Bard, Inc. and Ethicon, Inc.
Vaginal Mesh Lawsuits
Court documents indicate that American Medical Systems has been named in more than 20,000 vaginal mesh lawsuits filed on behalf of women who were allegedly injured by devices used to treat pelvic organ prolapse and stress urinary incontinence. The majority of these claims are currently pending in a federal multidistrict litigation now underway in U.S. District Court, Southern District of West Virginia. Jeffrey S. Grand, a partner with Bernstein Liebhard LLP, is serving on the Plaintiffs' Steering Committees for this proceeding. (In Re American Medical Systems, Inc. - MDL No. 2325)
Court records indicate that transvaginal mesh lawsuits involving American Medical Systems and other companies have been mounting in courts around the U.S. since 2008, when the U.S. Food & Drug Administration (FDA) issued its first of two warnings regarding the serious risks of vaginal mesh complications associated with these products. On April 28, 2014, the FDA announced it had “identified clear risks associated with surgical mesh for the transvaginal repair of pelvic organ prolapse,” prompting it to propose new rules that would subject such devices to greater regulatory scrutiny,
According to court filings, American Medical Systems is just one of several companies named in vaginal mesh lawsuits in the Southern District of West Virginia. In addition to his work on that litigation, Mr. Grand is also serving on the Plaintiffs' Steering Committees in several in proceedings established in that jurisdiction that involve Boston Scientific Corp., (MDL 2326), C.R. Bard, Inc. (MDL 2325) and Ethicon, Inc. (MDL No. 2327).
Mr. Grand is also serving as Co-Liaison Counsel in two consolidated proceedings established for C.R. Bard and Ethicon mesh lawsuits in New Jersey's Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).
Women who were allegedly injured by transvaginal mesh may be entitled to file their own vaginal mesh lawsuit. To learn more about the compensation that may be available to alleged victims of vaginal mesh complications, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*phx.corporate-ir.net/phoenix.zhtml?c=231492&p=irol-newsArticle_Print&ID=1924548&highlight=, Endo International PLC, April 30, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP